Targeted oxygen delivery via intravenous or intra-arterial infusion of oxygenated polymerized hemoglobin solutions

Details for Australian Patent Application No. 2008266938 (hide)

International Classifications

Event Publications

28 January 2010 PCT application entered the National Phase

PCT publication WO2008/156699 Priority application(s): WO2008/156699

28 April 2011 Amendment Made

The nature of the amendment is: Amend the name of the inventor to read Dube, Gregory P.; Zafirelis, G. Zafiris; Laccetti, Anthony J. and Baqai, Javed

19 May 2011 Corrigenda

Amendments - Amendments Made Under the name OPK Biotech LLC, Application No. 2008266938 under INID (72), correct the co-inventor to Zafirelis, Zafiris G.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.